CEFTAZIDIME IN DEXTROSE CONTAINER Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Ceftazidime In Dextrose Container, and when can generic versions of Ceftazidime In Dextrose Container launch?
Ceftazidime In Dextrose Container is a drug marketed by B Braun and is included in one NDA.
The generic ingredient in CEFTAZIDIME IN DEXTROSE CONTAINER is ceftazidime. There are seventeen drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the ceftazidime profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Ceftazidime In Dextrose Container
A generic version of CEFTAZIDIME IN DEXTROSE CONTAINER was approved as ceftazidime by ACS DOBFAR on November 20th, 1985.
Summary for CEFTAZIDIME IN DEXTROSE CONTAINER
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Clinical Trials: | 67 |
Formulation / Manufacturing: | see details |
DailyMed Link: | CEFTAZIDIME IN DEXTROSE CONTAINER at DailyMed |
Recent Clinical Trials for CEFTAZIDIME IN DEXTROSE CONTAINER
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Qianfoshan Hospital | N/A |
Arrevus Inc. | Phase 2 |
King Faisal Specialist Hospital & Research Center | Phase 3 |
Anatomical Therapeutic Chemical (ATC) Classes for CEFTAZIDIME IN DEXTROSE CONTAINER
US Patents and Regulatory Information for CEFTAZIDIME IN DEXTROSE CONTAINER
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
B Braun | CEFTAZIDIME IN DEXTROSE CONTAINER | ceftazidime | INJECTABLE;INJECTION | 050823-001 | Jun 13, 2011 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
B Braun | CEFTAZIDIME IN DEXTROSE CONTAINER | ceftazidime | INJECTABLE;INJECTION | 050823-002 | Jun 13, 2011 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |